Zydus Life Sciences Limited offers a wide range of products across various therapeutic areas such as ophthalmology, respiratory, gastroenterology, pain management, cardiovascular, anti-infectives, neurology, and dermatology.
Overview
Mentions in press and media 21
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 18, 2026 | Perfect Day is Coming Out of ‘Incognito Mode’ With Its Animal-Free Whey | 9 Mins Read Californian startup Perfect Day has spent two years in the sheds to solve the cost and scalability challenges of precision fermentation. Now, with the whey market in overdrive, it’s re-emerging as a “fundamentally stronger” busi... |
| Jul 10, 2026 | ChrysCapital’s open offer for Novartis India fails as shares surge | The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann Homegrown private equity firm ChrysCapital’s open offer to acquire additional shares of Novartis India Ltd has found no takers as the drugmaker’s share... |
| Jul 3, 2026 | Zydus ties up with Apollo Hospitals to expand access to multi-cancer blood test in India | |
| Jun 26, 2026 | Estrogen patches are hard to find, and it may not be resolved any time soon | Estrogen patches are hard to find as demand for menopause support skyrockets. Hormone replacement therapy has been becoming more popular as women share stories on social media and after the FDA removed a black box warning on the medications... |
| May 19, 2026 | Q4 Results Today Highlights: BEL, Dhanuka Agritech & RITES, Zydus Lifesciences, Eureka Forbes, Zee | financial background, money and finance concept with charts, fintech istock photo for BL | Photo Credit: anyaberkut Q4 Results Today, May 19, 2026: : Find all the highlights for Q4 results 2026 of Ace Alpha Tech, Adcounty Media India, Adven... |
| May 13, 2026 | Zydus to acquire US cancer drug company Assertio for $166.4 million in all-cash deal | Zydus Lifesciences announced on Wednesday that it had signed an agreement via its subsidiary to acquire Assertio Holdings Inc. for $166.4 million in an all-cash deal. Assertio is a Nasdaq-listed pharmaceutical company focused on specialty a... |
| Nov 18, 2025 | Zydus partners with SIG to launch single-serve spouted pouches for cough medicine | |
| Nov 10, 2025 | ‘New Milk’ signals new phase for recombinant dairy, says Remilk: ‘It doesn’t look like another alternative product’ | Israeli startup Remilk has partnered with family-owned dairy firm Gad Dairies to launch New Milk, a low-sugar, lactose-free milk featuring recombinant dairy proteins made in fermentation tanks, rather than from cows. While some players have... |
| Nov 6, 2025 | Zydus Lifesciences’ Q2 net profit soars 39% to ₹1,258 crore; Board approves ₹5,000 cr fundraising |
Reviews 0
FAQ about Zydus Lifesciences
When was Zydus Lifesciences founded?
Zydus Lifesciences was founded in 1952.
What has the press written about Zydus Lifesciences?
Parsers VC has collected 21 articles mentioning Zydus Lifesciences, among them “Perfect Day is Coming Out of ‘Incognito Mode’ With Its Animal-Free Whey” (Aug 18, 2026) and “ChrysCapital’s open offer for Novartis India fails as shares surge” (Jul 10, 2026).
Is Zydus Lifesciences still active?
Yes, Zydus Lifesciences is active; its latest activity on Parsers VC dates from Oct 28, 2026.